MacroGenics: 4Q Earnings Snapshot

ROCKVILLE, Md. (AP) _ MacroGenics Inc. (MGNX) on Tuesday reported a loss of $30.4 million in its fourth quarter.

On a per-share basis, the Rockville, Maryland-based company said it had a loss of 62 cents.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 71 cents per share.

The biopharmaceutical company posted revenue of $25.2 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $10.7 million.

For the year, the company reported that its loss narrowed to $151.8 million, or $3.16 per share. Revenue was reported as $64.2 million.

sonos sonos One (Gen 2) - Voice Controlled Smart Speaker with Amazon Alexa Built-in - Black read more

MacroGenics shares have risen 1% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $10.99, a decline of 49% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGNX at https://www.zacks.com/ap/MGNX

sonos sonos One (Gen 2) - Voice Controlled Smart Speaker with Amazon Alexa Built-in - Black read more

all right reserved for yahoo news

Get the latest news delivered to your inbox

Follow us on social media networks

NEXT Chuck Schumer tells Donald Trump he needs a military czar for coronavirus ...